乳腺癌术后乳腺内预防性放疗的研究进展及临床决策

中华放射肿瘤学杂志 Pub Date : 2019-12-15 DOI:10.3760/CMA.J.ISSN.1004-4221.2019.12.016

Yanbo Deng

{"title":"乳腺癌术后乳腺内预防性放疗的研究进展及临床决策","authors":"Yanbo Deng","doi":"10.3760/CMA.J.ISSN.1004-4221.2019.12.016","DOIUrl":null,"url":null,"abstract":"Although the internal mammary is the lymphatic drainage site for breast cancer, whether postoperative radiotherapy needs to be irradiated remains controversial. In recent years, several random studies have discussed internal mammary radiotherapy to varying degrees and no evidence has obtained that internal mammary radiotherapy bring clinical benefits to overall survival. In clinical practice, internal mammary prophylactic radiotherapy should maintain the balance among the risk of tumor recurrence, prescription dose and radiotherapy techniques to avoid the increased risk of radiotherapy-related death that offsets the possible survival benefits. \n \n \nKey words: \nBreast neoplasm/internal mammary prophylactic radiotherapy; Research progress; Clinical decision","PeriodicalId":10288,"journal":{"name":"中华放射肿瘤学杂志","volume":"28 1","pages":"949-952"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research progress and clinical decision of internal mammary prophylactic radiotherapy after breast cancer surgery\",\"authors\":\"Yanbo Deng\",\"doi\":\"10.3760/CMA.J.ISSN.1004-4221.2019.12.016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although the internal mammary is the lymphatic drainage site for breast cancer, whether postoperative radiotherapy needs to be irradiated remains controversial. In recent years, several random studies have discussed internal mammary radiotherapy to varying degrees and no evidence has obtained that internal mammary radiotherapy bring clinical benefits to overall survival. In clinical practice, internal mammary prophylactic radiotherapy should maintain the balance among the risk of tumor recurrence, prescription dose and radiotherapy techniques to avoid the increased risk of radiotherapy-related death that offsets the possible survival benefits. \\n \\n \\nKey words: \\nBreast neoplasm/internal mammary prophylactic radiotherapy; Research progress; Clinical decision\",\"PeriodicalId\":10288,\"journal\":{\"name\":\"中华放射肿瘤学杂志\",\"volume\":\"28 1\",\"pages\":\"949-952\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华放射肿瘤学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2019.12.016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华放射肿瘤学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2019.12.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

虽然内乳是乳腺癌的淋巴引流部位，但术后是否需要放疗仍存在争议。近年来，一些随机研究不同程度地讨论了乳腺内放疗，但没有证据表明乳腺内放疗对总体生存有临床益处。在临床实践中，乳腺内预防性放疗应保持肿瘤复发风险、处方剂量和放疗技术之间的平衡，以避免放疗相关死亡风险的增加抵消可能的生存获益。关键词:乳腺肿瘤/乳腺内预防性放疗;研究进展;临床决策

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Research progress and clinical decision of internal mammary prophylactic radiotherapy after breast cancer surgery

Although the internal mammary is the lymphatic drainage site for breast cancer, whether postoperative radiotherapy needs to be irradiated remains controversial. In recent years, several random studies have discussed internal mammary radiotherapy to varying degrees and no evidence has obtained that internal mammary radiotherapy bring clinical benefits to overall survival. In clinical practice, internal mammary prophylactic radiotherapy should maintain the balance among the risk of tumor recurrence, prescription dose and radiotherapy techniques to avoid the increased risk of radiotherapy-related death that offsets the possible survival benefits. Key words: Breast neoplasm/internal mammary prophylactic radiotherapy; Research progress; Clinical decision

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

中华放射肿瘤学杂志

自引率

0.00%

发文量

6375

期刊介绍： The Chinese Journal of Radiation Oncology is a national academic journal sponsored by the Chinese Medical Association. It was founded in 1992 and the title was written by Chen Minzhang, the former Minister of Health. Its predecessor was the Chinese Journal of Radiation Oncology, which was founded in 1987. The journal is an authoritative journal in the field of radiation oncology in my country. It focuses on clinical tumor radiotherapy, tumor radiation physics, tumor radiation biology, and thermal therapy. Its main readers are middle and senior clinical doctors and scientific researchers. It is now a monthly journal with a large 16-page format and 80 pages of text. For many years, it has adhered to the principle of combining theory with practice and combining improvement with popularization. It now has columns such as monographs, head and neck tumors (monographs), chest tumors (monographs), abdominal tumors (monographs), physics, technology, biology (monographs), reviews, and investigations and research.